Cancer Genetics Inc (NASDAQ:CGIX)

1.80
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.30
-2.70%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +233.33% increase from the last price of 1.80.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.11
Sales
$9.2M
Reporting Date
Mar 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -279.72%
 
 
 
 
 
 
Growthannually 21.00%
 
 
 
 
 
 

Sales

Growthquarterly 14.51%
 
 
 
 
 
 
Growthannually 13.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.